| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 10/10/2006 | US7119209 Process for preparing indolinone derivatives |
| 10/10/2006 | US7119206 drugs such as 12-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-7,12-dihydro-benzo[a]anthracene-3,9-diol, used for prevention of bone and cardiovascular disorders, as hypotensive, thrombolytic and anticholesterol agents |
| 10/10/2006 | US7119122 Compounds for the inhibition of nitric oxide synthase |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/05/2006 | WO2006104387A1 Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance |
| 10/05/2006 | WO2006104305A1 The lithium salts of pyrrolidinium type zwitterion and the preparation method of the same |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006103986A1 Process for production of optically active fluoroproline derivative |
| 10/05/2006 | WO2006103985A1 Process for production of fluorocompounds |
| 10/05/2006 | WO2006103696A2 Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives |
| 10/05/2006 | WO2006103690A1 A novel process for preparation of substantially pure glimepiride |
| 10/05/2006 | WO2006103057A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006103045A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | WO2006102760A1 Inhibitors of histone deacetylase |
| 10/05/2006 | WO2006020276A3 Antiviral compounds |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060224001 Hydrogenation catalysts |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223842 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia |
| 10/05/2006 | US20060223814 Nk-2 antagonist basic linear compounds and formulations containing them |
| 10/05/2006 | US20060223802 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223726 Photo-labile pro-fragrance conjugates |
| 10/05/2006 | US20060218854 Fuel Additive Composition and Fuel Composition and Method Thereof |
| 10/05/2006 | DE202005020766U1 Neue Kristallformen von Atorvastatin-Hemi-Calcium New crystal forms of atorvastatin hemi-calcium |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2603589A1 Inhibitors of histone deacetylase |
| 10/05/2006 | CA2603122A1 Phenyl and pyridyl lta4h modulators |
| 10/05/2006 | CA2602339A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602336A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 10/05/2006 | CA2602082A1 Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same, and compositions for imparting such resistance |
| 10/05/2006 | CA2582230A1 A novel process for preparation of substantially pure glimepiride |
| 10/04/2006 | EP1707559A1 Method of enanthio-selective nucleophilic addition reaction for conversion of enamide to imine and method of synthesizing alpha amino-gamma-keto acid ester |
| 10/04/2006 | EP1707556A1 Method of enantiometrically selective nucleophilic addition reaction to carbonyl of enamide and method of synthesizing optically active alpha-hydroxy-gamma-keto acid ester and hydroxydiketone |
| 10/04/2006 | EP1706402A1 Cathepsin cysteine protease inhibitors |
| 10/04/2006 | EP1706377A1 Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 10/04/2006 | EP1706376A1 Imidazole derivatives, processes for preparing them and their uses |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1412328B1 Dolastatin 10 derivatives |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1097382B1 Imidazoline receptor binding compounds |
| 10/04/2006 | CN1842517A 芴衍生物 Fluorene derivatives |
| 10/04/2006 | CN1842330A Glycosidase inhibitors and methods of synthesizing same |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277812C Preparation process of 1-chloro-3-(N-substituent)-tert-butyloxy formylamido-3-substituent-2-acetone |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115754 Pyrrolidine derivatives as oxytocin antagonists |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115750 Melanin concentrating hormone antagonist |
| 10/03/2006 | US7115738 Hydroxyproline/phosphono oligonucleotide analogues, methods of synthesis and methods of use |
| 10/03/2006 | US7115664 Peptidomimetic ligands for cellular receptors and ion channels |
| 10/03/2006 | US7115661 Methods and compositions for mitigating pain |
| 10/03/2006 | US7115652 Aspartyl protease inhibitors |
| 10/03/2006 | US7115642 Inhibits replication and/or proliferation of Hepatitis C virus (HCV) |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115632 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115600 Histamine-3 receptor modulators |
| 10/03/2006 | US7115596 Thiazole compounds as integrin receptor antagonists derivatives |
| 10/03/2006 | US7115541 Catalyst comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalyst |
| 10/03/2006 | CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/28/2006 | WO2006102071A1 Organic nitric oxide enhancing salts of angiotensin converting enzyme inhibitors, compositions and methods of use |
| 09/28/2006 | WO2006101828A1 Insecticidal alkylamino phenyl sulfonamide derivatives |
| 09/28/2006 | WO2006101808A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 09/28/2006 | WO2006101780A1 Mitotic kinesin inhibitors |
| 09/28/2006 | WO2006101062A1 Process for producing carbapenem derivative having 1-alkylpyrrolidine structure |
| 09/28/2006 | WO2006100922A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | WO2006100563A1 Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide |
| 09/28/2006 | WO2006100502A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | WO2006100479A1 Methods for the synthesis of heteroaromatic compounds |
| 09/28/2006 | WO2006100453A1 Glycopyrronium salts and their therapeutic use |
| 09/28/2006 | WO2006100106A1 3-carboxy pyrroles as anti-viral agents |
| 09/28/2006 | WO2006100039A1 Carboxanilides as microbiocides |
| 09/28/2006 | WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | WO2006099985A1 Rubber composition comprising an itaconimido-maleimide |
| 09/28/2006 | WO2006076246A3 Phenylglycinamide derivatives useful as anticoagulants |
| 09/28/2006 | WO2006074244A3 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 09/28/2006 | WO2006044975A3 Compositions and their use as anti-tumor agents |
| 09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/28/2006 | US20060217560 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217396 Benzoylguanidine salt and hydrates thereof |
| 09/28/2006 | US20060217310 Fibroblast growth factor 1 (FGF-1) used for skin care |
| 09/28/2006 | CA2602097A1 Process for producing carbapenem derivatives having 1-alkylpyrrolidine structure |
| 09/28/2006 | CA2601135A1 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 09/28/2006 | CA2600757A1 Pyrrolidine derivatives as histamine h3 receptor antagonists |
| 09/28/2006 | CA2600578A1 Carboxanilides as microbiocides |
| 09/28/2006 | CA2600063A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | CA2599794A1 Cinnamoyl compound and use thereof |
| 09/28/2006 | CA2599390A1 Mitotic kinesin inhibitors |
| 09/28/2006 | CA2598589A1 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 09/28/2006 | CA2597417A1 Organic nitric oxide enhancing salts of angiotensin converting enzyme inhibitors, compositions and methods of use |
| 09/27/2006 | EP1705175A1 Process for preparing C5 products and their use for Atorvastatin synthesis |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1704142A1 Protease inhibitors |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/27/2006 | CN1839120A Process for production of cis-4-fluoro-l-proline derivatives |
| 09/26/2006 | US7112671 And texaphyrin and sapphyrin compounds, as well as other polypyrrolic macrocycles, prepared using tripyrranes as a precursor; treatment of neoplastic tissue, neovascularization |